glp-1 weight loss drugs tirzepatide semaglutide How medications are transforming diabetes and treatment GLP-1 Wight Loss Program

As a precaution, patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) should discuss this with their clinician before considering any GLP-1-containing therapy

Starting Dose and Titration Semaglutide starts at a low dose (typically 0.25mg weekly) to minimize side effects while your body adjusts

O'Neil et al., 2018)

Why Use the Combo Instead of One Peptide

BMI 30 kg/m, or BMI 27 kg/m with at least one weight-related condition such as hypertension, type 2 diabetes, hyperlipidemia, or obstructive sleep apnea Documentation showing that diet, exercise, and other lifestyle-based weight management approaches have already been attempted No contraindications such as a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) These are general criteria